MRSN Shares Outstanding History
Below is a table of the MRSN shares outstanding history going back to 6/28/2017:

Date MRSN Shares Outstanding

Also see: MRSN Market Cap History
MRSN Historical Shares Outstanding:
+33.77% CAGR
MRSN Historical Shares Outstanding: +33.77% CAGR

Mouse over chart for data details
6/28/2017 ...5/6/2021
Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. Co.'s platforms which include Dolaflexin and Dolasynthen, delivering its DolaLock payload, as well as Immunosynthen. Co.'s product candidates include XMT-1536 and XMT-1592. XMT-1536, an ADC utilizing Co.'s Dolaflexin platform and targeting NaPi2b, an antigen broadly expressed in ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma is astudy including both a dose escalation cohort and two expansion cohorts in ovarian cancer and NSCLC adenocarcinoma. XMT-1592 uses one of Co.'s new platforms, Dolasynthen, and also targets NaPi2b. We show 18 historical shares outstanding datapoints in our coverage of MRSN's shares outstanding history.

Understanding the changing numbers of MRSN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MRSN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MRSN by allowing them to research MRSN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for MRSN:
MRSN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Mersana Therapeutics (MRSN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MRTX Shares Outstanding History
MSON Shares Outstanding History
MTEM Shares Outstanding History
MYGN Shares Outstanding History
MYL Shares Outstanding History
MYND Shares Outstanding History
MYOK Shares Outstanding History
NAOV Shares Outstanding History
NBIX Shares Outstanding History
NDRA Shares Outstanding History
More Healthcare companies »


MRSN Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.